Cashu
Pulse Biosciences: Leading Innovations in Bioelectric Therapy and Anticipating Earnings Growth
3 months ago
Stocks
Health Care
plse
Pulse Biosciences
NASDAQ: PLSE
+7.04 (+51.46%)
20.735
USD
At close at Feb 06, 21:40 UTC
Latest Pulse Biosciences News
benzinga.com
Earnings Scheduled For November 5, 2025
3 months ago
businesswire.com
Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360 Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium
about 1 year ago
businesswire.com
Pulse Biosciences’ Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium
about 1 year ago
businesswire.com
Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer
about 1 year ago
businesswire.com
Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer
about 1 year ago
businesswire.com
Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference
about 1 year ago
businesswire.com
Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
about 1 year ago
businesswire.com
Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association
over 1 year ago
businesswire.com
Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results
over 1 year ago
businesswire.com
Pulse Biosciences Announces Appointment of David Kenigsberg, M.D. as Chief Medical Officer of Electrophysiology
over 1 year ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.